NO20065535L - Behandling av respiratorisk sykdom - Google Patents

Behandling av respiratorisk sykdom

Info

Publication number
NO20065535L
NO20065535L NO20065535A NO20065535A NO20065535L NO 20065535 L NO20065535 L NO 20065535L NO 20065535 A NO20065535 A NO 20065535A NO 20065535 A NO20065535 A NO 20065535A NO 20065535 L NO20065535 L NO 20065535L
Authority
NO
Norway
Prior art keywords
treatment
respiratory disease
glycopyrrate
bronchospasm
analog
Prior art date
Application number
NO20065535A
Other languages
English (en)
Inventor
Susan Snape
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20065535L publication Critical patent/NO20065535L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Glykopyrrat eller en analog derav er anvendelig for behandling av bronkospasme eller som en førstehjelps- medisinering.
NO20065535A 2004-05-10 2006-11-30 Behandling av respiratorisk sykdom NO20065535L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410398.2A GB0410398D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001776 WO2005107872A2 (en) 2004-05-10 2005-05-10 Treating respiratory diseases with gycopyrrolate and analogues

Publications (1)

Publication Number Publication Date
NO20065535L true NO20065535L (no) 2006-12-08

Family

ID=32526759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065535A NO20065535L (no) 2004-05-10 2006-11-30 Behandling av respiratorisk sykdom

Country Status (14)

Country Link
US (1) US20080020048A1 (no)
EP (1) EP1750806A2 (no)
JP (1) JP2007536361A (no)
CN (1) CN1950127A (no)
AU (1) AU2005240404B2 (no)
BR (1) BRPI0510947A (no)
CA (1) CA2566339A1 (no)
GB (1) GB0410398D0 (no)
IL (1) IL178815A (no)
MX (1) MXPA06013039A (no)
NO (1) NO20065535L (no)
NZ (1) NZ550911A (no)
WO (1) WO2005107872A2 (no)
ZA (1) ZA200609967B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
CA2716936C (en) * 2008-02-26 2018-06-05 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
AU2013205983A1 (en) * 2008-02-26 2013-06-13 Sunovion Respiratory Development Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
WO2013137009A1 (ja) * 2012-03-14 2013-09-19 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
CA2895955A1 (en) * 2012-12-27 2014-07-03 Microdose Therapeutx, Inc. Dry powder inhalation formulation of oxybutynin and a pharmaceutically effective agent to treat respiratory disease
DK3689332T3 (da) 2014-09-09 2026-03-23 Vectura Ltd Formulering, som omfatter glycopyrrolat, fremgangsmåde og apparat
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
CN112137957B (zh) * 2019-06-26 2022-07-29 长风药业股份有限公司 一种药用吸入气雾剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
ES2309705T3 (es) * 2004-02-06 2008-12-16 MEDA PHARMA GMBH & CO. KG Nueva combinacion de anticolinergico y beta-mimeticos para el tratamiento de enfermedades respiratorias.
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease

Also Published As

Publication number Publication date
IL178815A (en) 2011-10-31
US20080020048A1 (en) 2008-01-24
BRPI0510947A (pt) 2007-11-20
AU2005240404B2 (en) 2009-04-23
IL178815A0 (en) 2007-05-15
WO2005107872A3 (en) 2006-03-16
EP1750806A2 (en) 2007-02-14
CN1950127A (zh) 2007-04-18
NZ550911A (en) 2010-10-29
CA2566339A1 (en) 2005-11-17
ZA200609967B (en) 2008-06-25
AU2005240404A1 (en) 2005-11-17
JP2007536361A (ja) 2007-12-13
MXPA06013039A (es) 2007-06-19
GB0410398D0 (en) 2004-06-16
WO2005107872A2 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
NO20065535L (no) Behandling av respiratorisk sykdom
NL300933I2 (nl) Letermovir
CO6491052A2 (es) Compuestos espirociclicos que contienen notrogeno y su uso medicinal
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
DK1556342T3 (da) Phenethanolaminderivat til behandling af respiratoriske sygdomme
NO20065878L (no) Terapeutiske forbindelser
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
CL2008002162A1 (es) Compuestos derivados de 3-benzoisoxazol-piperidin; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento y/o prevencion de trastornos cognitivos, adiccion a drogas, depresion, ansiedad, entre otras.
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
DK1817282T3 (da) Til behandling af respiratoriske sygdomme egnede phenoxy derivater
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
UY28774A1 (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes.
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20076405L (no) Anvendelse av 24-nor-UDCA
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
SE0200198D0 (sv) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application